Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Lilly's ixekizumab approved in Japan

July 4, 2016

Positive opinion handed down for Belkyra through European decentralized procedure

July 4, 2016

AstraZeneca and Leo Pharma announce licensing agreements for tralokinumab and brodalumab

July 1, 2016

Galderma Research & Development patents retinoid RORgammaT inverse agonists

July 1, 2016

Cara Therapeutics discloses phase II results on CR-845

June 30, 2016

Chugai and Maruho launch Marduox combination topical ointment for psoriasis vulgaris

June 22, 2016

PRX-003: first-in-human data

June 15, 2016

BioSpecifics Technologies reports positive results on CCH phase II trial

June 14, 2016

Revance discontinues development of RT-001 for lateral canthal lines on basis of phase III results

June 14, 2016

Fibrocell Science starts recruiting patients in study of FCX-007

June 14, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...